)
Skin Analytics
Hall: N7 - N10 Stand: A21
- | Applied AI
- | Clinical Imaging and diagnostics
- | Patient Pathways
)
Skin Analytics builds AI interventions that enable innovative dermatology pathways to deliver better patient outcomes and sustainability for health systems, globally.
Using the only UKCA Class IIa AI as a Medical Device (AIaMD) for dermatology, we're proud to be working with the NHS to build world leading skin cancer pathways.
Since 2020, Skin Analytics has assessed over 81,000 NHS patients for suspicion of skin cancer, helping Secondary Care organisations remove the need for more than 64% of face-to-face NHS urgent suspected skin cancer appointments.
We want to build a future where no one dies from skin cancer.
Address
4th Floor, Kingsbourne House, 229-231 High HolbornLondon
WC1V 7EG
United Kingdom
Contact Exhibitor
Products
-
)
Skin Analytics supports NHS dermatology teams by creating patient pathways that leverage our AI as a Medical Device (AIaMD), DERM, to help triage patients to the right place at the right time.
News
-
)
AI dermatology company Skin Analytics is aiming to build on its position as the only holder of a Class IIa medical device in the UK to rebuild patient pathways in the country and improve outcomes. -
Skin Analytics publishes research examining perspectives of 268 patients at Chelsea & Westminster Hospital who are currently using AI to identify skin cancer and support early diagnosis and treatment. -
)
NHS Confederation's briefing with AstraZeneca feature Skin Analytics as an example of successful partnerships that improve NHS services.